. Author manuscript; available in PMC: 2020 Feb 1.

Published in final edited form as: Cancer Causes Control. 2019 May 16;30(8):819–826. doi: 10.1007/s10552-019-01178-y

Table 3.

Probabilistic sensitivity analysis results from the NBCCEDP

Scenario	Incremental costs (95% CI)	Incremental QALYs (95% CI)	ICER (95% CI)
Versus no program	$1,228 ($654, $2,147)	0.024 (0.011, 0.040)	$56,615 ($24,069, $134,230)
Median	[$1,189]	[0.024]	[$50,097]
Versus no screening	$3,533 ($1,807, $5,766)	0.07 (0.052, 0.088)	$51,096 ($26,423, $97,315)
Median	[$3,340]	[0.070]	[$48,049]

Medians in brackets

ICER incremental cost-effectiveness ratio expressed as $ per QALY, NBCCEDP National Breast and Cervical Cancer Early Detection Program; QALYs quality-adjusted life-years; 95% confidence intervals (CI) presented in parentheses